Skip to main contentSkip to navigationSkip to search

Press releases and news

2025

Camurus’ Board of Directors exercises authorization for repurchase of shares for the purpose of securing the company’s commitments under the Performance Share Plan 2025/2028

Resolutions at the annual general meeting 2025 in Camurus

Camurus to present at Jefferies Global Healthcare Conference

Camurus’ Interim Report January-March 2025

Camurus appoints Anders Vadsholt as Chief Financial Officer

Camurus launches Buvidal® weekly and monthly in Portugal

Camurus Annual Report for 2024

CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU

Notice of annual general meeting 2025 in Camurus AB (publ)

Camurus’ CEO Fredrik Tiberg receives The Arthur D. Little Nordic Life Science Award

Camurus receives EthiFinance ESG Platinum Medal

Jon Garay Alonso will leave position as Camurus’ CFO

Camurus’ Full Year Report 2024

Camurus’ fourth quarter and full year 2024 earnings above previous estimates

Buvidal® weekly and monthly – now available to patients in Switzerland

2024

Change in number of shares and votes in Camurus

Camurus’ Nomination Committee appointed for the Annual General Meeting 2025

Camurus to present at Jefferies London Healthcare Conference

Camurus’ Interim Report Third Quarter 2024

Camurus improves ESG rating score by MSCI

Load more press releases

Subscribe

Get the latest news from Camurus

Subscribe to receive latest news from Camurus directly to your email. 

Information types

By subscribing to news from Camurus, you agree to our privacy policy.

Thank you. You will get an e-mail message to activate your subscription.